Hundreds of laid-off CDC employees are being reinstated
NEW YORK (AP) — More than 460 laid-off employees at the nation's top public health agency received notices Wednesday that they are being reinstated, according to a union representing the workers.
The U.S. Department of Health and Human Services confirmed reinstatement notices went out to the former Centers for Disease Control and Prevention employees, but provided few details.
About 2,400 CDC employees lost their jobs in a wave of cuts across federal health agencies in early April, according to a tally at the time.
Whole CDC programs were essentially shut down, including some focused on smoking, lead poisoning, gun violence, asthma and air quality, and workplace safety and health. The entire office that handles Freedom of Information Act requests was shuttered. Infectious disease programs took a hit, too, including programs that fight outbreaks in other countries, labs focused on HIV and hepatitis in the U.S., and staff trying to eliminate tuberculosis.
An estimated 200 of the reinstated workers are based in the CDC's National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention, HHS officials confirmed. Staffers at a CDC lab that does testing for sexually transmitted diseases are being brought back, said one CDC employee who wasn't authorized to discuss what happened and spoke to The Associated Press on condition of anonymity.
Also reinstated are an estimated 150 employees at the CDC's National Center for Environmental Health, including people staffing a lab that works on lead poisoning, according to the union and employees.
Layoffs at federal agencies were challenged in lawsuits, with judges in some cases ordering federal agencies to halt terminations of employees.
Officials at HHS have never detailed how they made the layoff decisions in the first place. And they did not answer questions about why the notices went out, or how decisions were made about who to bring back.
HHS spokesperson Andrew Nixon said the agency was streamlining operations and that 'the nation's critical public health functions remain intact and effective.'
'The Trump Administration is committed to protecting essential services — whether it's supporting coal miners and firefighters through NIOSH, safeguarding public health through lead prevention, or researching and tracking the most prevalent communicable diseases,' he said.
This is not the first time that employees at the Atlanta-based agency were told they were being terminated only to then be told to come back. After an earlier round of termination notices went out in February, about 180 CDC employees in March were told to come back.
__
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
an hour ago
- Toronto Star
House passes bill to to combat fentanyl trafficking, sending it to Trump's desk
WASHINGTON (AP) — The House overwhelmingly passed bipartisan legislation Thursday that would solidify federal policies cracking down on the synthetic opioid fentanyl and its analogs in a bid by lawmakers to combat the nation's opioid epidemic. The HALT Fentanyl Act makes permanent a 2018 emergency rule that classifies knockoffs of fentanyl as Schedule I controlled substances, which results in harsher sentences for possession of the drug. The bill passed the House 321-104 and now heads to President Donald Trump for his signature.
Winnipeg Free Press
2 hours ago
- Winnipeg Free Press
House passes bill to to combat fentanyl trafficking, sending it to Trump's desk
WASHINGTON (AP) — The House overwhelmingly passed bipartisan legislation Thursday that would solidify federal policies cracking down on the synthetic opioid fentanyl and its analogs in a bid by lawmakers to combat the nation's opioid epidemic. The HALT Fentanyl Act makes permanent a 2018 emergency rule that classifies knockoffs of fentanyl as Schedule I controlled substances, which results in harsher sentences for possession of the drug. The bill passed the House 321-104 and now heads to President Donald Trump for his signature. The legislation, which applies to what are known as known as 'fentanyl-related substances,' garnered support from nearly every Republican and many Democrats despite concerns that the bill does not address the root issues at hand and will add to problems in the criminal justice system. Senate Majority Leader John Thune hailed passage of the bill and promised more legislative action to come. 'I don't need to tell anybody about the horrible impact of drug overdoses in this country, many of them caused by fentanyl,' Thune said on the Senate floor. 'In the coming weeks, we'll be taking up legislation to address another aspect of the fight: securing our borders,' a nod to Republicans' tax package, which includes billions of dollars in additional immigration enforcement and border security funding. Proponents of the legislation argue that the bill will make it easier to stop drug traffickers by making the federal emergency rules permanent. Opponents say the framework does little to stem the epidemic and warn it will make it harder to conduct important research. Congress has regularly renewed the emergency rules since 2018, meaning there is no immediate change to federal policy. The bill does not include increased funding for law enforcement to conduct anti-drug trafficking efforts, nor funding for public health efforts meant to reduce fentanyl addiction and deaths. The bill's supporters say that the reclassification will give anti-trafficking efforts clearer standards to operate under as law enforcement combats the trade. Federal, state and local law enforcement have sought to break up the flow of fentanyl into the U.S. by targeting Mexican drug cartels and local gangs. The Trump administration has declared stemming the flow of fentanyl precursors from China a priority in trade talks with Beijing, an effort that follows a spate of initiatives by the Biden administration to reduce the importation of such substances into the U.S. from China and other illegal supply chains. 'A loophole that the cartels have tried to use to drive their illicit fentanyl into our country is by changing one part of the fentanyl chemical structure to create fentanyl analogs,' said GOP Virginia Rep. Morgan Griffith, one of the bill's co-sponsors, during Wednesday's debate on the House floor. 'The cartels did this in an attempt to evade our criminal laws,' said Griffith, who argued that the bill would help prevent further fentanyl deaths and increase the potential for research into the drug and related substances. And lawmakers appealed to the human cost of fentanyl smuggling. 'We must give our law enforcement the tools to combat this problem. This bill does exactly that,' said GOP California Rep. Jay Obernolte, a co-sponsor of the bill. Obernolte recounted the stories of families impacted by fentanyl overdoses in his district and noted that more than 100,000 Americans died of an overdose last year, mostly from fentanyl. The bill 'gives our law enforcement agencies the tools that they need to begin dealing with this problem,' Obernolte said. Democratic New Jersey Rep. Frank Pallone said during debate that he opposed the bill because it uniformly criminalizes fentanyl related substances. Pallone said it will impede potential research into their benefits rather than provide an 'offramp to substances found to have potential medical applications.' Pallone also chided Republicans for saying they aimed to tackle the opioid epidemic while supporting the Trump administration's cuts to federal agencies tasked with research and public health policy. 'This Republican bill would also exacerbate inequities in our criminal justice system because drugs placed on Schedule I include mandatory minimum sentencing,' Pallone said. 'The bill is essentially recycling an incarceration first response to what I consider mainly a public health challenge.' Schedule I drugs are substances considered by the Drug Enforcement Agency to have 'no currently accepted medical use and a high potential for abuse.' Possession of a Schedule I drug is considered a felony and can be prosecuted as drug smuggling. Drugs currently classified as Schedule I include heroin, marijuana and methaqualone. Fentanyl itself is classified as a Schedule II drug, which the DEA designates as having 'a high potential for abuse.' Schedule II substances include cocaine, methamphetamine, oxycodone and Adderall.
Globe and Mail
12 hours ago
- Globe and Mail
Canadian researchers await potential update to breastfeeding guidelines for women with HIV
Researchers are waiting to see if a review by Health Canada will update guidance for mothers living with HIV who wish to breastfeed, noting the department's policy is more restrictive than those of countries such as the United States and Switzerland and runs contrary to a growing body of scientific evidence. Health Canada currently advises against breastfeeding for women living with HIV because of the risk of transmitting the virus. Women and parents living with HIV have expressed concerns about the guidance because they say breast milk strengthens a baby's immune system and helps reinforce an emotional connection between mother and child. They point to research showing that antiretroviral therapy (ART) – a combination of medications to treat HIV – can significantly reduce viral load and lower the risk of HIV transmission, even in cases of individuals living with HIV who choose to breastfeed, though it does not entirely eliminate the risk. This year, Health Canada expects to complete the initial stage of a broad review of its Nutrition for Healthy Term Infants policy. It is first looking at nutritional policy for infants from birth to six months of age. A second stage will consider nutrition for children six months to 24 months old. The department says a joint working group is leading the process and it plans to post draft guidelines online for consultation. Saskatchewan struggles to stem highest HIV rate in Canada as cases rise across the country Provinces should cover weight-loss drugs for people with pre-existing cardiovascular disease, says drug agency Jason Brophy, who chairs the Canadian Pediatric and Perinatal HIV/AIDS Research Group, said that if Health Canada's guidance is revised, breastfeeding should be recommended only for mothers with long-term viral suppression. He cautioned, though, that mothers should adhere to treatment and remain in care. 'The baby must be closely monitored by trained health care professionals,' said Dr. Brophy, a pediatric infectious disease specialist at the Children's Hospital of Eastern Ontario. His research group currently recommends formula feeding exclusively but argues that women with consistently undetectable viral loads who wish to breastfeed should receive appropriate counselling and support. Still, there are calls from within the group to go further. Mothers or parents with undetectable HIV should have equal access to both breast/chest feeding and formula feeding options, said Logan Kennedy, the research lead at Women's College Hospital in Toronto and a member of the research group. A 2019 Canadian study published in the Journal of the Pediatric Infectious Disease Society examined the use of combination antiretroviral therapy prophylaxis, a treatment that prevents the virus from replicating. It followed three breastfed infants whose mothers had sustained virologic suppression and received the therapy. All three babies remained HIV-negative. Sarah Khan, a pediatric infectious disease specialist at McMaster Children's Hospital in Hamilton, said not every baby who breastfeeds from a mother living with HIV will become infected. 'In many low-resource countries, the benefits of breastfeeding outweigh the risks, and several measures can help keep babies safe,' Dr. Khan said. In the Canadian study, she said, mothers took strict precautions to prevent breast inflammation, a known risk factor for transmission, and their newborns were given HIV medications as an additional layer of protection. In 2016, the World Health Organization recommended breastfeeding for women living with HIV on ART in low- and middle-income countries where formula may not be affordable or culturally accepted, difficult to use or continue over time or unsafe owing to unclean water. It also said countries that do not promote breastfeeding among mothers living with HIV must ensure access to lifelong ART and consistent adherence counselling. Three years later, Switzerland advised women on ART to choose either breastfeeding or formula use. In 2023, the U.S. also said mothers living with HIV who are virally suppressed should breastfeed or use formula or donor breast milk. Dr. Khan said safe breastfeeding is possible when HIV is controlled, breasts are properly cared for and preventative infant prophylaxis treatment is in place. She hopes health providers will be able to utilize new guidelines and evidence so they can have informed discussions with families affected by HIV to decide on the best approach for a mother and baby. Dr. Khan is also leading new research called the MILK Study, tracking mothers living with HIV who choose to breastfeed. There are plans to analyze breast milk during high-risk periods, such as when an infant is ill or a mother has inflammation of the breast tissue.
